Stocktoria
Wellgistics Health, Inc. WGRX
Nasdaq · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 2025-02-21
Wellgistics Health, Inc. financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $23.3M | $18.1M | — |
| Gross profit | -$6.4M | $1.8M | — |
| Operating income | -$93.7M | -$6.1M | -$2.9M |
| Net income | -$101.3M | -$6.9M | -$2.9M |
| EPS (diluted) | $-1.43 | $-0.15 | $-0.06 |
| Operating cash flow | -$10.9M | -$1.2M | -$349,136 |
| Cash & equivalents | $42,571 | $1.0M | $1,364 |
| Inventory | $1.6M | $9.5M | — |
| Total assets | $30.5M | $57.3M | $338,364 |
| Total liabilities | $42.9M | $50.6M | $3.2M |
| Shareholders' equity | -$12.4M | $6.7M | -$2.9M |
Growth · year-over-year · Revenue CAGR 28.7%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | +28.7% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.